Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · IEX Real-Time Price · USD
9.17
-0.14 (-1.50%)
Mar 28, 2024, 10:30 AM EDT - Market open

Ocular Therapeutix Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
58.4451.4943.5217.44.231.991.921.891.750.77
Upgrade
Revenue Growth (YoY)
13.49%18.32%150.08%311.71%112.41%3.48%1.91%7.83%126.68%-
Upgrade
Cost of Revenue
5.284.544.412.082.330.470.460.440.320.09
Upgrade
Gross Profit
53.1646.9539.1215.321.91.531.471.441.430.68
Upgrade
Selling, General & Admin
74.4972.1567.0749.4746.6123.7332.5117.7113.028.9
Upgrade
Research & Development
61.0653.4650.0828.6941.0936.9230.8827.0726.6118.88
Upgrade
Operating Expenses
135.54125.61117.1578.1787.760.6463.3944.7739.6327.78
Upgrade
Operating Income
-82.38-78.65-78.04-62.85-85.8-59.12-61.92-43.33-38.2-27.09
Upgrade
Interest Expense / Income
11.347.026.676.776.11.741.891.681.721.12
Upgrade
Other Expense / Income
-12.98-14.64-78.1686.02-5.53-0.88-0.43-0.3-0.170.44
Upgrade
Pretax Income
-80.74-71.04-6.55-155.64-86.37-59.98-63.39-44.7-39.75-28.65
Upgrade
Net Income
-80.74-71.04-6.55-155.64-86.37-59.98-63.39-44.7-39.75-28.65
Upgrade
Preferred Dividends
0000000000.01
Upgrade
Net Income Common
-80.74-71.04-6.55-155.64-86.37-59.98-63.39-44.7-39.75-28.66
Upgrade
Shares Outstanding (Basic)
80777661453829252311
Upgrade
Shares Outstanding (Diluted)
86838261453829252311
Upgrade
Shares Change
3.57%0.59%35.24%34.19%18.78%32.26%16.13%6.76%118.20%308.31%
Upgrade
EPS (Basic)
-1.01-0.92-0.09-2.56-1.91-1.57-2.20-1.80-1.71-2.69
Upgrade
EPS (Diluted)
-1.02-0.97-0.98-2.56-1.91-1.57-2.20-1.80-1.71-2.69
Upgrade
Free Cash Flow
-76.32-63.32-66.74-54.4-79.82-51.12-58.72-35.92-35.51-21.76
Upgrade
Free Cash Flow Per Share
-0.96-0.82-0.87-0.90-1.76-1.34-2.04-1.45-1.53-2.04
Upgrade
Gross Margin
90.96%91.18%89.88%88.03%45.00%76.63%76.24%76.52%81.77%88.21%
Upgrade
Operating Margin
-140.96%-152.74%-179.30%-361.13%-2029.86%-2970.75%-3220.12%-2296.03%-2182.69%-3509.59%
Upgrade
Profit Margin
-138.14%-137.95%-15.06%-894.31%-2043.34%-3013.97%-3296.20%-2369.00%-2271.31%-3712.31%
Upgrade
Free Cash Flow Margin
-130.59%-122.96%-153.36%-312.56%-1888.24%-2568.64%-3053.56%-1903.44%-2029.37%-2818.13%
Upgrade
EBITDA
-66.42-61.912.54-146.1-77.74-55.95-59.87-42.14-37.27-26.98
Upgrade
EBITDA Margin
-113.64%-120.22%5.83%-839.48%-1839.15%-2811.71%-3113.31%-2233.28%-2129.71%-3495.08%
Upgrade
Depreciation & Amortization
2.982.112.422.772.532.291.630.880.750.55
Upgrade
EBIT
-69.4-64.020.12-148.87-80.27-58.24-61.49-43.02-38.02-27.53
Upgrade
EBIT Margin
-118.74%-124.32%0.27%-855.42%-1899.01%-2926.58%-3197.82%-2279.97%-2172.80%-3565.93%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).